ArticleCancer2022

Patients with completely resected nongenitourinary low-risk embryonal rhabdomyosarcoma are candidates for reduced duration low-intensity chemotherapy.

Gianni Bisogno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.